K. Lindpaintner et al., A PROSPECTIVE EVALUATION OF AN ANGIOTENSIN-CONVERTING-ENZYME GENE POLYMORPHISM AND THE RISK OF ISCHEMIC-HEART-DISEASE, The New England journal of medicine, 332(11), 1995, pp. 706-711
Background. In a previous study, men with a history of myocardial infa
rction were found to have an increased prevalence of homozygosity for
the deletional allele (D) of the angiotensin-converting-enzyme (ACE) g
ene, The D allele is associated with higher levels of ACE, which may p
redispose a person to ischemic heart disease. We investigated the asso
ciation between the ACE genotype and the incidence of myocardial infar
ction, as well as other manifestations of ischemic heart disease, in a
large, prospective cohort of U.S. male physicians, Methods. In the Ph
ysicians' Health Study, ischemic heart disease as defined by angina, c
oronary revascularization, or myocardial infarction developed in 1250
men by 1992, They were matched with 2340 controls according to age and
smoking history. Zygosity for the deletion-insertion (D-I) polymorphi
sm of the ACE gene was determined by an assay based on the polymerase
chain reaction, Data were analyzed for both matched pairs and unmatche
d samples, with adjustment for the effects of known or suspected risk
factors by conditional and non-conditional logistic regression, respec
tively. Results. The ACE genotype was not associated with the occurren
ce of either ischemic heart disease or myocardial infarction, The adju
sted relative risk associated with the D allele was 1.07 (95 percent c
onfidence interval, 0.96 to 1.19; P = 0.24) for ischemic heart disease
and 1.05 (95 percent confidence interval, 0.89 to 1.25; P = 0.56) for
myocardial infarction, if an additive mode of inheritance is assumed,
Additional analyses assuming dominant and recessive effects of the D
allele also failed to show any association, as did the examination of
low-risk subgroups, Conclusions. In a large, prospectively followed po
pulation of U.S. male physicians, the presence of the D allele of the
ACE gene conferred no appreciable increase in the risk of ischemic hea
rt disease or myocardial infarction.